Multigene Expression Signatures in Early Hormone Receptor Positive HER 2 Negative Breast Cancer

BACKGROUND: The standard treatment of hormone receptor positive, HER2 negative early breast cancer (BC) is surgery followed by adjuvant systemic therapy either with endocrine therapy alone or with the addition of chemotherapy followed by endocrine therapy. Adjuvant systemic therapy reduces the risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Ovcaricek, Tanja, Takac, Iztok, Matos, Erika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6765159/
https://www.ncbi.nlm.nih.gov/pubmed/31553709
http://dx.doi.org/10.2478/raon-2019-0038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6765159/
https://www.ncbi.nlm.nih.gov/pubmed/31553709
http://dx.doi.org/10.2478/raon-2019-0038

Ejemplares similares